VEXIM receives Australian approval for SpineJack, Masterflow: 4 highlights

VEXIM, a France-based company developing medical devices for the minimally invasive treatment of vertebral fractures, received regulatory approval to commercialize its SpineJack implant and Masterflow system in Australia.

Advertisement

Here are four highlights:

 

1. Australia’s Therapeutic Goods Administration approved the two devices.

 

2. VEXIM plans to commercially launch these two products in Australia by the end of 2016.

 

3. SpineJack is intended to restore a fractured vertebra to its initial shape and restore the spinal column’s anatomy.

 

4. The Masterflow system offers a solution for mixing and injecting orthopedic cement to improve the accuracy of injection.

 

More articles on devices:
Dr. Michael Vitale to use NuVasive’s MAGEC system during live surgery event: 6 highlights
4 thoughts on Medtronic stock after the latest earnings report
J&J, Globus Medical, Exactech & more: 8 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.